Milla Maria Koistinaho
Fundador en Aranda Pharma Oy .
Origen de la red de primer grado Milla Maria Koistinaho.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Innovestor Oy
 Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014.
12
| Private Company | Investment Managers | 12 |
Innovestor Ventures Oy
 Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland.
12
| Subsidiary | Investment Managers | 12 |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Tribune Therapeutics AB
 Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Aranda Pharma Oy
 Aranda Pharma Oy BiotechnologyHealth Technology Aranda Pharma Ltd. engages in the research and development of novel small molecules to combat prostate cancer and neurodegenerative diseases. The company was founded by Anu Muona, Milla Koistinaho, Jari Koistinaho, and Gundars Goldsteins in September 2015 and is headquartered in Kuopio, Finland.
6
| Holding Company | Biotechnology | 6 |
Teitur Trophics ApS
 Teitur Trophics ApS BiotechnologyHealth Technology Teitur Trophics ApS develops novel treatments. The company is based in Aarhus, Denmark. The Danish company was founded by Simon Mølgaard, Mathias Kaas Ollendorff, Anders Dalby, Simon Glerup. Simon Mølgaard has been the CEO since incorporation.
5
| Holding Company | Biotechnology | 5 |
Suomen Bioteollisuus ry
3
| Private Company | 3 | |
Helsinki Innovation Services Ltd.
 Helsinki Innovation Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Helsinki, Helsinki Innovation Services Ltd. is a company that provides business and innovation-related consulting services. The company is based in Helsinki, Finland.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Milla Maria Koistinaho a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal | |
| ACCENTURE PLC | Information Technology Services | Corporate Officer/Principal | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Chief Executive Officer | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Founder Private Equity Analyst Private Equity Investor | |
| Stanford University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| SSAB AB | Metal Fabrication | Public Communications Contact | |
| ORION OYJ | Pharmaceuticals: Major | Chief Executive Officer | |
| RAUTARUUKKI CORPORATION | Steel | Investor Relations Contact | |
| MEDIGENE AG | Biotechnology | Corporate Officer/Principal | |
Finnvera Oyj
 Finnvera Oyj Finance/Rental/LeasingFinance Finnvera Oyj is a financing company that provides financing for the start-up, growth, and internationalization of enterprises and for protection against export risks. Its products include loans, domestic guarantees, export credit guarantees, venture capital investments, export credits, and interest equalization. The company was founded on July 9, 1998 and is headquartered in Kuopio, Finland. | Finance/Rental/Leasing | Director/Board Member Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Medicel Oy
 Medicel Oy Information Technology ServicesTechnology Services Medicel Oy develops and provides software services for reverse engineering and modeling of biochemical pathways for drug discovery and validation. The company's product platforms include Medicel Integrator, Medicel Explorer, and Medicel Services. Medicel was founded in March 2001 and is headquartered in Espoo, Finland | Information Technology Services | Corporate Officer/Principal | |
Philip Morris USA, Inc.
 Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Tobacco | Corporate Officer/Principal | |
| BIORETEC OY | Medical Specialties | Director/Board Member | |
| Aalto University | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Helsinki | College/University | Graduate Degree Public Communications Contact Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Veraventure Oy
 Veraventure Oy Investment ManagersFinance Veraventure Oy is a venture capital investment firm based in Kuopio, Finland. Established in 2003, they are a wholly-owned subsidiary of Finnvera Oy. Veraventure is responsible for the management and development of the parent firm's investments linked to regional funds. Finnvera is a specialized financing firm, owned and operated by the Finnish Government and supervised by the Ministry of Trade and Industry. Veraventure specializes in complementing regional markets in equity financing. They have a particular focus on early-stage financing as well as providing capital related to generational changes and for small and mid-size firms. They are the investment manager of the Seed Fund Vera. The firm also has offices in Oulu and Helsinki, Finland. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Corporate Officer/Principal | |
Fermion Oy
 Fermion Oy Pharmaceuticals: MajorHealth Technology Fermion Oy develops, manufactures and markets active pharmaceutical ingredients. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | Chairman | |
Glycotope GmbH
 Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
MediSapiens Oy
 MediSapiens Oy Packaged SoftwareTechnology Services MediSapiens Oy provides solutions for bioinformatics analysis. It offers software and products for biological research. The firm creates customized bioinformatics software solutions to organizations; ranging from data management system, to full sample and data processing system, to an animal deoxyribonucleic acid testing service. Its products include Biond Explorer; Research Integrator; IST Online; Target Scout; and Fusion Scout. The company was founded by Sami Kalevi Kilpinen, Olli-Pekka Kallioniemi, and Tommi Pisto in 2009 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member Corporate Officer/Principal | |
| Tampere University of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Bitbar Technologies Oy
 Bitbar Technologies Oy Packaged SoftwareTechnology Services Bitbar Technologies Oy provides mobile software development and testing solutions for mobile app and game developers. The firm offers Testdroid recorder to automatically generate standards-based test scripts and Testdroid server for companies to build in-house test labs. It has offices in Helsinki, Oulu, San Francisco, and Wroclaw. The company was founded by Marko Tapani Kaasila and Jouko Juhani Kaasila in 2009 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Corporate Officer/Principal | |
| Aalto University School of Business | College/University | Graduate Degree Undergraduate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
HealthCap Advisor AB
 HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Chief Executive Officer | |
Memo Therapeutics AG
 Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Chief Executive Officer | |
| Neurotar Oy | Director/Board Member | ||
Meles Consulting Oy
 Meles Consulting Oy Miscellaneous Commercial ServicesCommercial Services Meles Consulting Oy provides management consulting services. The private company is based in Espoo, Finland. The CEO of the Finnish company is Pekka Ilmari Simula. | Miscellaneous Commercial Services | Chief Executive Officer | |
| SITOWISE GROUP OYJ | Information Technology Services | Director/Board Member | |
Sitowise Oy
 Sitowise Oy Information Technology ServicesTechnology Services Sitowise Oy provides built environment services. Its offer includes building and infrastructure design, project planning, research, inspection, strategic consulting, sustainability, digital, and environment and energy related services. The company was founded in 2017 and is headquartered in Espoo, Finland. | Information Technology Services | Director/Board Member | |
| Aalto University School of Science & Technology | College/University | Doctorate Degree | |
| Procom Oy | Director/Board Member | ||
| Sartar Therapeutics Oy | Director/Board Member | ||
HVR Cardio Oy
 HVR Cardio Oy Medical SpecialtiesHealth Technology HVR Cardio Oy is a Finnish cardiovascular device company that is developing breakthrough solutions for mitral valve repair based on its proprietary helix technology. The company is based in Espoo, Finland. The company's lead products, CathHELIX® and MAR®, are transcatheter and surgical mitral valve repair devices that are designed to be faster, easier to use, and less invasive without compromising clinical efficacy. The company was founded by Olli Urho Tapani Keränen, and Tom Fleming has been the CEO of the company since 2022. | Medical Specialties | Director/Board Member |
Estadísticas
Internacional
| Finlandia | 33 |
| Estados Unidos | 5 |
| Suecia | 5 |
| Suiza | 4 |
| Alemania | 4 |
Sectorial
| Health Technology | 19 |
| Technology Services | 8 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 5 |
Operativa
| Director/Board Member | 146 |
| Corporate Officer/Principal | 52 |
| Chairman | 45 |
| Chief Executive Officer | 39 |
| Private Equity Investor | 29 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Milla Maria Koistinaho
- Conexiones Empresas
